|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.12 EUR | -1.14% |
|
-6.07% | +35.42% |
| 08:11pm | Moody's Upgrades Bayer Outlook With Rating Affirmation on "Positive" Court Decision | MT |
| 11/07 | Bayer in the red despite an improved balance sheet structure thanks to Apollo | DP |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAYER AG | Other Pharmaceuticals | -1.14% | -6.07% | +35.42% | +83.32% | -1.40% | 56.29B |  | | |
- Stock Market
- Stocks
- BAYN Stock
- Charts Bayer AG
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition